InvestorsObserver
×
News Home

Should Biotechnology Stock Tricida Inc (TCDA) Be in Your Portfolio Tuesday?

Tuesday, November 29, 2022 12:11 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Tricida Inc (TCDA) Be in Your Portfolio Tuesday?

The 62 rating InvestorsObserver gives to Tricida Inc (TCDA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, TCDA’s 62 overall rating means the stock scores better than 62 percent of all stocks.

Overall Score - 62
TCDA has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on TCDA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tricida Inc Stock Today?

Tricida Inc (TCDA) stock is trading at $0.26 as of 12:11 PM on Tuesday, Nov 29, a decline of -$0.02, or -8.32% from the previous closing price of $0.28. The stock has traded between $0.24 and $0.29 so far today. Volume today is less active than usual. So far 12,463,623 shares have traded compared to average volume of 18,803,835 shares. Click Here to get the full Stock Report for Tricida Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App